Overview

Lofexidine for Opiate Withdrawal - 1

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate lofexidine for opiate withdrawal.
Phase:
Phase 3
Details
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
Collaborator:
Britannia Pharmaceuticals Ltd.
Treatments:
Clonidine
Lofexidine